DICE Therapeutics (NASDAQ:DICE) reported quarterly losses of $(0.55) per share. This is a 74.42 percent increase over losses of $(2.15) per share from the same period last year.
Treasury Yields Have Started Falling, Can The Markets Breath A Sigh Of Relief?
Yields on treasury notes are pulling back from their 2022 highs, while the stock market appears to be recovering from its 9-month-long bear run.
